(Q51984249)

19 April 2018

title

Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. (English)

1 reference

19 April 2018

obsessive-compulsive disorder

main subject

1 reference

A V Ravindran

1

1 reference

19 April 2018

J Griffiths

series ordinal

2

1 reference

19 April 2018

Z Merali

series ordinal

3

1 reference

19 April 2018

H Anisman

series ordinal

4

1 reference

19 April 2018

publication date

1 January 1999

1 reference

19 April 2018

Journal of Affective Disorders

published in

1 reference

19 April 2018

volume

52

1 reference

19 April 2018

issue

1-3

1 reference

19 April 2018

page(s)

1-10

1 reference

19 April 2018

T cell subsets in obsessive-compulsive disorder

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Coping behavior in depression: report on a new scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Effects of experimental psychological stress on distribution and function of peripheral blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Neuroendocrine measures and lymphocyte subsets in depressive illness: influence of a clinical interview concerning life experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Depression and immunity: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

The dexamethasone suppression test in patients with primary obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Acute psychological stressors and short-term immune changes: what, why, for whom, and to what extent?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Evidence for an immune response in major depression: a review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Depression, adrenal steroids, and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Selective serotonin reuptake inhibitors in OCD

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Scaling of Life Events

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Variations of lymphocyte subsets associated with stress in depressive populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Primary dysthymia: a study of several psychosocial, endocrine and immune correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Increased CD56+ natural killer cells and related cytokines in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Depression and immunocompetence: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Cytokine production in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

Drug treatment of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900072-X

7 January 2021

10.1016/S0165-0327(98)00072-X

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018